Healthcare -
Biotechnology - NASDAQ - US
$ 57.18
1.35 %
$ 7.27 B
Market Cap
18.93
P/E
Price Target
Average
--5.56%
Revenue Forecast
Estimate
30.26%
EBIT
Estimate
22.02%
Net Income
Estimate
61.49%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Halozyme Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for HALO of $54 , with forecasts ranging from
a
low of
$44 to a high of $65 .
HALO Lowest Price Target
Wall Street Target
44 USD
-23.05%
HALO Average Price Target
Wall Street Target
54 USD
-5.56%
HALO Highest Price Target
Wall Street Target
65 USD
13.68%
REVENUE FORECAST
Revenue Forecast Chart HALO
EBIT FORECAST
EBIT Forecast Chart HALO
NET INCOME FORECAST
Net Income Chart HALO